AstraZeneca PLC (AZNCF) Financials
AZNCF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 114.1 billion | 65.4 billion |
| Sept. 30, 2025 | 114.5 billion | 68.5 billion |
| June 30, 2025 | 112.4 billion | 67.6 billion |
| March 31, 2025 | 106.3 billion | 65.2 billion |
AZNCF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | 1.1 billion | ? |
| Sept. 30, 2025 | 4.4 billion | ? |
| June 30, 2025 | 1.5 billion | ? |
| March 31, 2025 | 3.4 billion | ? |
AZNCF Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | 2.3 billion |
| Sept. 30, 2025 | 2.5 billion |
| June 30, 2025 | 3.1 billion |
| March 31, 2025 | 3.0 billion |
AZNCF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | - | - | 1.8 billion |
| Sept. 30, 2025 | 8.2 billion | 26.1 billion | 1.8 billion |
| June 30, 2025 | 7.1 billion | 26.0 billion | 1.6 billion |
| March 31, 2025 | 5.4 billion | 27.9 billion | 1.6 billion |
AZNCF Shares Outstanding
AZNCF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 1.3 billion | 3.9 billion | 5.6 billion | - |
| Sept. 30, 2025 | 686.0 million | 3.7 billion | 5.1 billion | 148.0 million |
| June 30, 2025 | 1.9 billion | 3.5 billion | 5.0 billion | 143.0 million |
| March 31, 2025 | 440.0 million | 3.2 billion | 4.6 billion | 132.0 million |
AZNCF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 15.5 billion | 3.1 billion |
| Sept. 30, 2025 | 15.2 billion | 2.9 billion |
| June 30, 2025 | 14.5 billion | 2.5 billion |
| March 31, 2025 | 13.6 billion | 2.2 billion |
AZNCF
Price: $187.45
Dividend Yield: 1.56%
Forward Dividend Yield: 4.63%
Payout Ratio: 47.51%
Dividend Per Share: 8.68 USD
Earnings Per Share: 6.03 USD
P/E Ratio: 33.46
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Market Capitalization: 312.8 billion
Average Dividend Frequency: 3
Years Paying Dividends: 18
DGR3: 30.00%
DGR5: 19.57%
DGR10: 9.73%